|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,045 KRW | -0.24% |
|
-5.76% | -27.99% |
GeneOne Life Science, Inc. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was KRW 111.46 million compared to KRW 231.76 million a year ago. Net loss was KRW 9,480.63 million compared to KRW 13,212.15 million a year ago.
Basic loss per share from continuing operations was KRW 121 compared to KRW 170 a year ago. Basic loss per share was KRW 121 compared to KRW 170 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -27.99% | 118M | |
| +38.65% | 39.36B | |
| -8.62% | 38.52B | |
| +26.95% | 30.74B | |
| +10.74% | 25.92B | |
| -13.50% | 26.03B | |
| +44.87% | 14.13B | |
| +34.36% | 12.73B | |
| -7.14% | 11.29B | |
| -12.61% | 10.64B |
GENEONE LIFE SCIENCE, INC. 
